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Abstract 
The CB1 cannabinoid receptor is targeted in the brain by endocannabinoids under 
physiological conditions as well as by delta9-tetrahydrocannabinol under cannabis use. Furthermore, 
its signaling appears to affect brain cognitive processing. Recent findings highlight a crucial role of 
cyclooxygenase-2 (COX-2) in the mechanism of intraneuronal CB1 signaling transduction, while others 
indicate that two single nucleotide polymorphisms (rs1406977 and rs20417) modulate expression of 
CB1 (CNR1) and COX-2 (PTGS2) coding genes, respectively. Here, our aim was to use fMRI to 
investigate in healthy humans whether these SNPs interact in modulating prefrontal activity during 
working memory processing and if this modulation is linked with cannabis use. We recruited 242 
healthy subjects genotyped for CNR1 rs1406977 and PTGS2 rs20417 that performed the N-back 
working memory task during fMRI and were interviewed using the Cannabis Experience 
Questionnaire (CEQ). We found that the interaction between CNR1 rs1406977 and PTGS2 rs20417 is 
associated with dorsolateral prefrontal cortex (DLPFC) activity such that specific genotype 
configurations (CNR1 C carriers/PTGS2 C carriers and CNR1 TT/PTGS2 GG) predict lower cortical 
response versus others in spite of similar behavioral accuracy. Furthermore, DLPFC activity in the 
cluster associated with the CNR1 by PTGS2 interaction was negatively correlated with behavioral 
efficiency and positively correlated with frequency of cannabis use in cannabis users. These results 
suggest that a genetically modulated balancing of signaling within the CB1-COX-2 pathway may reflect 
on more or less efficient patterns of prefrontal activity during working memory. Frequency of 
cannabis use may be a factor for further modulation of CNR1/PTGS2-mediated cortical processing 
associated with this cognitive process.  
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1. Introduction 
 A growing body of evidence is increasingly disambiguating the relationship between 
cannabinoid signaling and brain functions (Mouslech and Valla, 2009). In this regard, previous findings 
suggest the relevance of cannabinoids for the modulation of cognitive processing (Ruiz-Contreras et 
al., 2013, Ruiz-Contreras et al., 2014), as revealed by studies in humans indicating that prefrontal 
mediated working memory processing is compromised under acute effects of delta9-
tetrahydrocannabinol (Δ9-THC) (Bossong et al., 2012a, Bossong et al., 2012b, D'Souza et al., 2012) — 
the main psychoactive component of cannabinoids. Consistently, other results reveal that cannabis use 
during adolescence is associated with increased risk for cognitive impairments in healthy subjects 
(Jacobus et al., 2009, Malone et al., 2010, van Winkel and Kuepper, 2014). 
 Cannabinoid signaling in the brain targets two pertussis toxin sensitive G-protein-coupled 
receptors, CB1and CB2 (Matsuda et al., 1990, Munro et al., 1993). However, CB1 is the main mediator 
of cannabinoids effects on brain physiology (Pertwee, 2008). This receptor is widely expressed on 
axons and terminals of both glial elements and neurons (Matsuda, 1997) throughout the whole central 
nervous system including the dorsolateral prefrontal cortex (DLPFC) (Pazos et al., 2005). Recent 
evidence has also shed light on molecular mechanisms of intraneuronal CB1 signaling transduction for 
which the cyclooxygenase-2 (COX-2) has a crucial role (Chen et al., 2013). In particular, previous 
results have indicated that pro-inflammatory and excitotoxic processes implicate stimulation of CB1 
by the endogenous cannabinoid 2-arachidonylglycerol (2-AG), which in turn suppresses COX-2 activity 
(Zhang and Chen, 2008) via a mechanism mediated by the αi subunit of G protein (Zhang and Chen, 
2008). However, an alternate mechanism is induced by exposure to Δ9-THC, whose stimulation of CB1 
increases COX-2 transcription, expression, and activity via a mechanism mediated by the G protein βγ 
subunit (Chen et al., 2013). COX-2 in neurons and astroglial cells is key for the conversion of 
arachidonic acid (AA) into prostaglandins (Smith et al., 2000), that could in turn stimulate glutamate 
release in presynaptic nerve terminals and astroglial cells (Bezzi et al., 1998, Sanzgiri et al., 1999, Chen 
et al., 2002, Sang et al., 2005, Dave et al., 2010). Overall, this knowledge suggests that the relationship 
between CB1 and COX-2 is relevant for neuronal metabolism and signaling. Consistently, a recent work 
indicates that the CB1-COX-2 pathway activated by Δ9-THC affects synaptic plasticity and spatial 
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learning in mice (Chen et al., 2013). This also highlights a role of CB1 signals mediated by COX-2 in 
modulating complex phenotypes at the level of neuronal systems as well as of behavior. 
 Furthermore, evidence has indicated that genetic variation has functional consequences 
on expression of CB1 and COX-2 coding genes and predicts physiological, behavioral and 
clinical phenotypes. Specifically, a recent study (Colizzi et al., 2015) revealed that a single nucleotide 
polymorphism (SNP) rs1406977 (A/G) is associated with expression of the CB1 coding gene (CNR1 - 
6q14-q15) in post-mortem human prefrontal cortex as well as with cognitive behavior and related 
brain physiology. In particular, rs1406977 G carriers compared with AA individuals had lower 
prefrontal CNR1 mRNA post-mortem expression in non-psychiatric individuals. Furthermore, G 
carriers who were cannabis users had greater ventrolateral prefrontal connectivity and lower 
accuracy during working memory than homozygous A subjects (Colizzi et al., 2015). Other studies 
have also indicated that a SNP (rs20417 – G>C) in the promoter region of the COX-2 gene (PTGS2 –
1q31.1) is associated with its transcriptional activity. In particular, the C allele predicted lower COX-2 
expression than the G allele in human fibroblasts (Papafili et al., 2002, Gomez-Lira et al., 2014).  
 The combination of information from the functional effects of genetic variation and brain 
imaging is a viable approach to probe in vivo the interaction between different partners within 
signaling pathways on system level phenotypes. With this perspective, the aim of this study was to 
investigate with fMRI in humans whether CNR1 rs1406977 and PTGS2 rs20417 interact in modulating 
dorsolateral prefrontal working memory processing. Given that (1) these SNPs have functional effects 
on gene expression, (2) COX-2 crucially participates in intraneuronal CB1 signaling transduction, and 
(3) cannabinoid signaling is relevant for cognitive abilities, we hypothesized a modulatory effect of 
PTGS2 rs20417 on the relationship between CNR1 rs1406977 and dorsolateral prefrontal working 
memory processing. Furthermore, we hypothesized a relationship between CNR1/PTGS2 modulated 
dorsolateral prefrontal working memory processing and measures of cannabis use. 
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2. Materials and Methods 
2.1 Subjects 
 We enrolled 242 healthy subjects (126 males, age mean ± standard deviation 26.72 ± 7.32 
years). This sample included 208 individuals investigated in a previous study (Colizzi et al., 
2015). All subjects were Caucasians from the region of Puglia, Italy. Exclusion criteria were presence of 
any psychiatric disorder as evaluated with the Structured Clinical Interview for the Diagnostic and 
Statistical Manual of Mental Disorders IV; any significant neurological or medical condition revealed 
by clinical and magnetic resonance imaging; history of head trauma with loss of consciousness; active 
cannabis use during the study protocol as well as the use of other stimulant drugs. The Wechsler Adult 
Intelligence Scale—Revised was used to evaluate the Intelligence Quotient (IQ), the Hollingshead Scale 
to calculate the socio-economical status on the basis of educational attainment and occupational 
prestige (Hollingshead and Redlich, 1958), and the Edinburgh Inventory (Oldfield, 1971) to measure 
handedness. All participants were asked about their use of illicit drugs and those who reported 
cannabis use were interviewed using the Cannabis Experience Questionnaire (CEQ) (Di Forti et al., 
2009, Connor et al., 2011), which allows to obtain detailed information about cannabis use habits such 
as lifetime use (yes/no) and frequency of use (score range: 1-5, with 1 corresponding to exposure to 
cannabis few times during life, and 5 corresponding to cannabis consumption many times a day). The 
CEQ administration resulted in 160 non-users and 82 users. The local institutional review board 
approved the protocol. After complete description of the study to all the subjects, written informed 
consent was obtained.  
 
2.2 Genotype determination 
 Participants underwent venipuncture for subsequent DNA extraction from peripheral blood 
mononuclear cells. Approximately 200 ng DNA were used for genotyping analysis. DNA was 
concentrated at 50 ng/µl (diluted in 10 mM Tris/1mM EDTA) with a Nanodrop Spectrophotometer 
(ND-1000). We used Illumina HumanHap550K/610Quad Bead Chips (San Diego, California) to 
genotype our sample. Briefly, each sample was whole-genome amplified, fragmented, precipitated and 
resuspended in appropriate concentrations of hybridization buffer. Denatured samples were 
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hybridized on prepared Illumina Human550K/610-Quad Bead Chips. After hybridization, the Bead 
Chip oligonucleotides were extended by a single labeled base, which was detected by fluorescence 
imaging with an Illumina Bead Array Reader. Normalized bead intensity data obtained for each sample 
were loaded into the Illumina GenomeStudio (Illumina, v.2010.1) with cluster position files provided 
by Illumina, and fluorescence intensities were converted into SNP genotypes. We focused on CNR1 
rs1406977 and PTGS2 rs20417. Given the low number of homozygous subjects for the CNR1 
rs1406977 C allele (N = 8) and for the PTGS2 rs20417 G allele (N = 2), they were collapsed with 
heterozygous individuals in one group (CNR1 rs1406977 C carriers and PTGS2 rs20417 G carriers, 
respectively) for all analyses. On this basis, there were 65 CNR1 TT/PTGS2 CC, 76 CNR1 TT/PTGS2 G 
carriers, 33 CNR1 C carriers/PTGS2 CC, and 68 CNR1 C carriers/PTGS2 G carriers (Table 1).  
 
2.3 N-Back working memory paradigm  
 During fMRI, all subjects completed a block-designed paradigm of the N-Back task. Briefly, ‘N-
back’ refers to how far back in the sequence of stimuli the subject had to recall. The stimuli consisted 
of numbers (1–4) shown in a random sequence and displayed at the points of a diamond-shaped box. 
The task required recollection of a stimulus seen one or two stimuli previously (1-Back or 2-Back 
respectively) while subjects continued to encode additionally incoming stimuli. There was also a non-
memory-guided control condition (0-Back) that simply required subjects to identify the stimulus 
currently seen. Two different task runs were used, each alternating four 30-s blocks of a 0-Back 
condition with four 30-s blocks of a working memory condition (1- or 2-Back, respectively). Each run 
lasted 4 min and 8 s. Stimuli were presented via a back projection system, and behavioral responses 
were recorded through an optic fiber response box that allowed measurement of accuracy (percent of 
correct responses) and reaction time (milliseconds) for each trial. All subjects were trained on the task 
before the fMRI session. 
 
2.4 Analysis of behavioral data 
 Analysis of behavioral data was performed using a factorial ANCOVA with PTGS2 rs20417 and 
CNR1 rs1406977 genotypes as independent variables, lifetime frequency of cannabis use (0 for non 
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users, 1-5 for users) as a covariate of no interest, and a score indexing behavioral efficiency during 1 
and 2 back as the repeated measures factor.  This score was computed as the ratio between N-back 
accuracy (percentage of correct responses) and reaction time (milliseconds)(Salthouse et al., 2003, 
Pergola et al., 2016). Thus, higher efficiency values indexed better behavioral performance. Fisher's 
test was used for post hoc analysis. 
 
2.5 fMRI data acquisition and analysis 
 Blood oxygen level-dependent (BOLD) fMRI was performed on a GE Signa 3-T scanner (General 
Electric, Milwaukee, WI) equipped with a standard quadrature head coil. A gradient-echo planar 
imaging sequence (repetition time: 2,000 ms; echo time: 28 ms; 20 interleaved axial slices; thickness: 4 
mm; gap: 1 mm; voxel size: 3.75×3.75×5; flip angle: 90°; field of view: 24 cm; and matrix: 64×64) was 
used to acquire 120 volumes for each task run. The first four scans were discarded to allow for a T1 
equilibration effect.  
 Analysis of the fMRI data was completed using Statistical Parametric Mapping 8 (SPM8), 
http://www.fil.ion.ucl.ac.uk/spm). Images of each subject were pre-processed using the Realign and 
Unwarp tool within SPM8 to compensate for non-linear signal distortions potentially induced by head 
motion. Movement parameters were extracted to possibly exclude subjects with excessive head 
motion (> 3.5 mm in translation and 3.5 degrees in rotation). None of the individuals included in 
this study were excluded on this basis. Then, images were spatially normalized into the Montreal 
Neurological Institute (MNI) template (12-parameter affine model) and spatially smoothed (6 mm 
Gaussian filter). A boxcar model convolved with the hemodynamic response function (HRF) at each 
voxel was modeled. In the first-level analysis, linear contrasts were computed producing a t statistical 
map at each voxel for the 1- and 2-Back conditions, assuming the 0-Back condition as a baseline. Thus, 
all individual contrast images were entered in a group random-effects analysis. Specifically, a 
factorial ANCOVA was performed, with PTGS2 and CNR1 genotypes as the between-subjects 
factors, N-Back load as the repeated measures factor, and lifetime frequency of cannabis use (0 
for non users, 1-5 for users) as a covariate of no interest. We used a statistical threshold of p<0.05, 
family-wise error corrected using as volume of interest the Brodmann's areas (BA) included in 
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bilateral DLPFC (BA9, BA10, and BA46), which is the prefrontal region mainly involved in working 
memory processing (Callicott et al., 1999, Zhang et al., 2007, Bertolino et al., 2009a, Bertolino et al., 
2009b, Fazio et al., 2011, Colizzi et al., 2015). BAs were identified with the Wake Forest University 
PickAtlas (http://fmri.wfubmc.edu/cms/software#PickAtlas). To exclude that the results were due 
to the inclusion of subjects with a history of cannabis use in the larger sample, we also 
performed with SPM8 a factorial ANOVA in the non users subsample (N= 160), with PTGS2 and 
CNR1 genotypes as the between-subjects factors, and N-Back load as the repeated measures 
factor. As a region of interest, we used the DLPFC cluster in which there was a significant 
genotype/genotype interaction in the analysis with the mixed sample (see results). A statistical 
threshold of p<0.05, small volume corrected within the region of interest, was used in this case.  
 
2.6 Correlation analysis 
 To explore the relationship between behavior and genetically modulated DLPFC activity, we 
performed Pearson's r correlation analysis entering the BOLD parameter estimates extracted with 
MarsBaR (http://marsbar.sourceforge.net/) as variables from the cluster in which a PTGS2x CNR1 
interaction was present (see ‘Results’) as well as the mean behavioral efficiency during 1 and 2 Back. 
The same BOLD parameter estimates were further used in a Pearson’s test exploring the relationship 
between DLPFC activity and frequency of cannabis use in cannabis users, as measured with the CEQ. 
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3. Results 
3.1 Behavioral data  
 Genotype groups were matched for age, IQ, handedness (all F< 0.7; all p > 0.05), gender (χ2 
<2.89; p> 0.05), cannabis use (χ2 <7.4; p>0.05) as well as cannabis frequency of use (p>0.05). Factorial 
ANCOVA on behavioral efficiency at the N-back task indicated a main effect of CNR1 rs1406977 (F = 
4.3; p = 0.04), with TT subjects having better efficiency scores than C carriers. Furthermore, there was 
neither an effect of PTGS2 rs20417 (F = 2.4; p = 0.1) nor a PTGS2 rs20417 by CNR1 rs1406977 
interaction (F = 0.004; p = 0.9). Moreover, no significant interactions between genotypes and working 
memory load were found (all F < 1; all p > 0.05). 
 
3.2 fMRI data 
 ANCOVA on imaging data revealed a main effect of PTGS2 rs20417 in right BA10 (x: 32, y: 
52, z: 32; K = 149; Z = 4.21) with PTGS2 rs20417 C carriers having greater activity when 
compared to GG individuals. No main effect of CNR1 rs1406977 was found. Furthermore, there 
was an interaction between PTGS2 rs20417 and CNR1 rs1406977 in BA9 (x: 52, y: 26, z: 36; K = 
139 ; Z = 4.27) (Fig. 1a). Here, post hoc analysis on parameter estimates extracted from the significant 
cluster revealed that in the context of PTGS2 rs20417 C carriers, C carriers for CNR1 rs1406977 have 
lower BOLD responses relative to TT individuals; conversely, in the context of PTGS2 rs20417 GG 
individuals, CNR1 rs1406977 TT subjects have lower BOLD responses relative to individuals carrying 
the C allele (all p< 0.033; fig.1b). There were no genotype by load interactions.  
 The interaction between CNR1 rs1406977 and PTGS2 rs20417 on the BA9 cluster found 
with the investigation of the whole sample was also present  when investigating the sample of 
non-users only (x: 52, y: 26, z: 36; K = 53; Z = 3.77). Here, post hoc analysis indicated that 
patterns of BOLD responses as a function of PTGS2 and CNR1 genotypes overlapped with those 
revelaed by the analysis on the entire sample (all p<0.049). 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3.3 Correlation analysis 
 Pearson’s test indicated a negative correlation between BOLD parameter estimates extracted 
from the cluster in BA9 associated with a significant CNR1 by PTGS2 interaction and the behavioral 
efficiency index in the entire sample (r = -0.23; p = 0.0001; Fig.2). Furthermore, BA9 parameter 
estimates were also positively correlated with frequency of cannabis use in cannabis users (r = 0.34; 
p = 0.004; Fig. 3).  
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4. Discussion 
 We found that the interaction between two functional polymorphisms predicting expression of 
CNR1 and PTGS2 genes is associated with dorsolateral prefrontal activity during a working memory 
task. This finding suggests for the first time that genetic variations affect signaling of the CB1-COX2 
pathway and interact in modulating dorsolateral prefrontal processing during working memory in 
healthy humans. The data also suggest possible mechanisms by which cannabinoid signaling may 
modulate dorsolateral prefrontal working memory processing in humans. 
 The DLPFC is a working memory related brain region (Callicott et al., 1999, Bertolino et al., 
2009a, Bertolino et al., 2009b) where both CB1 and COX-2 are highly expressed (Lichtman and Martin, 
1996, Minghetti, 2004, Hoffman et al., 2007, Puighermanal et al., 2009, Fan et al., 2010, Han et al., 
2012). In particular, our results indicate that modulation of DLPFC BOLD activity by CNR1 rs1406977 
genotypes is differentially shaped as a function of PTGS2 rs20417 in the absence of a 
genotype/genotype interaction on behavioral data. In more detail, C carriers for CNR1 rs1406977 had 
lower BOLD responses relative to CNR1 TT individuals in the context of PTGS2 rs20417 C carrying 
subjects. On the other hand, an opposite pattern was present in the context of PTGS2 rs20417 G 
homozygosity. There were lower BOLD responses in CNR1 TT subjects compared to individuals 
carrying the C allele. 
These results may be interpreted considering previous findings indicating that physiological activation 
of CB1 receptors induces COX-2 suppression (Zhang and Chen, 2008) and others suggesting that CNR1 
rs1406977 and PTGS2 rs20417 genetically modulate CB1 and COX-2 expression, respectively (Papafili 
et al., 2002, Chen et al., 2013, Gomez-Lira et al., 2014, Colizzi et al., 2015). In particular, it is possible 
that the different genotype configurations are associated with differential signaling within the CB1-
COX-2 pathway so that DLPFC activity is more or less efficient. In other words, CNR1 Ccarriers/ 
PTGS2 GG and CNR1 TT/PTGS2 Ccarriers, compared with CNR1 Ccarriers/ PTGS2 Ccarriers and 
CNR1 TT/PTGS2 GG, may have greater need to recruit more prefrontal resources to perform the 
working memory task with the same behavioral proficiency, i.e., they are associated with lower 
DLPFC efficiency (Callicott et al., 2003). This interpretation is speculative in nature and awaits 
further experiments, but is consistent with current models of prefrontal function underlying 
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working memory (Callicott et al., 2003) and is supported by our correlation analysis indicating 
that the greater the DLPFC activity, the lower the behavioral performance during the N-back. Beyond 
this interpretation, these results support the involvement of CB1 in mechanisms of modulation of 
dorsolateral prefrontal function during working memory via its interaction with COX-2 signaling. 
 We also found that cannabis users have DLPFC activity during working memory that was 
positively correlated with the frequency of cannabis use. Consistent with this line of reasoning, this 
relationship may indicate that the greater the frequency of use of cannabis, the lower the DLPFC 
efficiency during working memory processing. Accordingly, previous findings suggested a link 
between increased cannabis use and inefficient dorsolateral prefrontal processing during working 
memory (Bossong et al., 2012a). Interestingly, we found this relationship in a brain region whose 
activity is modulated by the interaction between CNR1 and PTGS2 genetic variations. Thus, a further 
suggestion driven by our results is a link between working memory processing, habit of cannabis use, 
and genetic modulation of CB1/COX-2 signaling. This suggestion is also supported by knowledge 
indicating that activation of CB1 by Δ9-THC increases COX-2 expression and activity (Chen et al., 
2013), which in turn stimulates pre-synaptic glutamate release via a mechanism mediated by PGE2 
(Bezzi et al., 1998, Sanzgiri et al., 1999, Chen et al., 2002, Sang et al., 2005, Dave et al., 2010). Indeed, 
glutamate is crucially involved in working memory processing (Castner et al., 2004, Goldman-Rakic et 
al., 2004, Cohen Kadosh et al., 2015, Colizzi et al., 2016).  
Our results did not indicate an interaction between CNR1 rs1406977 and PTGS2 rs20417 on 
behavioral efficiency during working memory. The association of genetic variation with imaging 
phenotypes in spite of a lack of behavioral effects is a common finding in the imaging genetics 
literature (Bertolino and Blasi, 2009). This suggests that imaging correlates may better capture subtle 
genetic effects as opposed to behavior. Indeed, the biological distance between genes effects and 
imaging phenotypes is shorter compared to those of behavioral phenotypes. This may explain 
differential power of detection of the consequences of genetic variations at the imaging vs. behavioral 
levels. Furthermore, in our study, we tested subtle genetic interactions that were even more difficult to 
detect without larger sample sizes when looking at behavioral correlates. Consistently, we found a 
behavioral association when testing the main effect of CNR1 rs1406977. 
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 One limitation of this study is that we did not test the potential interaction between CNR1 
rs1406977 and PTGS2 rs20417 genotype, and cannabis use because the limited number of subjects 
would have excessively affected the statistical power of the analysis. On the other hand, we softened 
the potential effect of cannabis use on our data using frequency of cannabis use as a covariate in our 
statistical models. More in general, a larger sample size would have further corroborated the 
generalizability of the results of the present study. Another possible limitation is the lack of a 
laboratory drug screening, which would have represented a more reliable measure of cannabis 
consumption than CEQ. Finally, our study does not address the relationship between genetic 
variation and cannabis abuse. However, this investigation was beyond our aims and should be 
the object of further research.  
 
5. Conclusion 
 In conclusion, our results suggest that genetic modulation of CB1/COX-2 signaling 
affects dorsolateral prefrontal physiology during working memory in humans and that habits 
of cannabis use are linked with this modulation. Further studies are needed to address the 
potential relevance of this signaling pathway for psychiatric conditions characterized by anomalous 
prefrontal processing during cognition.  
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 Figures and Table Caption 
 
Table 1: Demographics of the study subjects.  
Figure 1: (a) Rendered image of the brain illustrating the interaction between PTGS2 rs20417 and 
CNR1 rs1406977 on fMRI response during working memory in right BA9 (x: 52, y: 26, z: 36). (b) 
Parameter estimates extracted from the cluster illustrated in (a); post hoc analysis revealed that in 
the context of PTGS2 rs20417 C carriers, C carriers for CNR1 rs1406977 have lower BOLD 
responses relative to TT individuals; conversely, in the context of PTGS2 rs20417 GG 
individuals, CNR1 rs1406977 TT subjects have lower BOLD responses relative to individuals 
carrying the C allele (all p< 0.033). 
Figure 2: Scatterplot of the relationship between parameter estimates extracted from the DLPFC 
cluster associated with a PTGS2 rs20417 by CNR1 rs1406977 interaction and behavioral efficiency 
during working memory (r = -0.23; p = 0.0001). 
Figure 3: Scatterplot of the relationship between parameter estimates extracted from the cluster in 
DLPFC associated with a PTGS2 rs20417 by CNR1 rs1406977 interaction and cannabis use frequency 
in cannabis users (r = 0.34; p = 0.004). 
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CNR1 
rs1406977  
PTGS2 
rs20417 
N M/F Age  
Socio-economic 
Status 
Handedness IQ 
Cannabis 
User/Non User 
Frequency of 
cannabis use 
in cannabis 
users  
TT GG 65 35/30 27,85 + 6,75 42,34 + 18,06 0,72 + 0,42 108,51 + 18,61 18/47 2,5 + 1,32 
TT C carriers 76 39/37 25,88 + 5,46 45,38 + 16,26 0,77 + 0,39 109,1 + 11,31 35/41 2,43 + 1,28 
C carriers GG 33 21/12 27,36 + 7,7 38,35 + 19,27 0,74 + 0,36 109,62 + 12,56 10/23 3,38 + 1,5 
C carriers C carriers 68 32/36 27,18 + 7,89 41,21 + 16,12 0,82 + 0,36 108,96 + 12,70 19/49 2,94 + 1,11 
Total 242 127/115 26,98 + 6,87 42,45 + 17,22 0,76 + 0,39 108,95 + 14,33 82/160 2,68 + 1,29 
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